Annual report pursuant to Section 13 and 15(d)

Earnings Per Common Share

v3.8.0.1
Earnings Per Common Share
12 Months Ended
Dec. 31, 2017
Earnings Per Share [Abstract]  
Earnings Per Common Share
Earnings Per Common Share
The calculation of EPS and diluted EPS for 2017, 2016 and 2015 is presented below. For more information on the calculation of EPS, see Note 1 – Summary of Significant Accounting Principles.
 
 
 
 
 
 
(Dollars in millions, except per share information; shares in thousands)
2017
 
2016
 
2015
Earnings per common share
 
 
 

 
 
Net income
$
18,232

 
$
17,822

 
$
15,910

Preferred stock dividends
(1,614
)
 
(1,682
)
 
(1,483
)
Net income applicable to common shareholders
$
16,618

 
$
16,140

 
$
14,427

Average common shares issued and outstanding
10,195,646

 
10,284,147

 
10,462,282

Earnings per common share
$
1.63

 
$
1.57

 
$
1.38

 
 
 
 
 
 
Diluted earnings per common share
 

 
 

 
 
Net income applicable to common shareholders
$
16,618

 
$
16,140

 
$
14,427

Add preferred stock dividends due to assumed conversions (1)
186

 
300

 
300

Net income allocated to common shareholders
$
16,804

 
$
16,440

 
$
14,727

Average common shares issued and outstanding
10,195,646

 
10,284,147

 
10,462,282

Dilutive potential common shares (2)
582,782

 
762,659

 
773,948

Total diluted average common shares issued and outstanding
10,778,428

 
11,046,806

 
11,236,230

Diluted earnings per common share
$
1.56

 
$
1.49

 
$
1.31

(1) 
Represents the Series T dividends under the “if-converted” method prior to conversion.
(2) 
Includes incremental dilutive shares from RSUs, restricted stock and warrants.
In connection with an investment in the Corporation’s Series T preferred stock in 2011, the Series T holders also received warrants to purchase 700 million shares of the Corporation’s common stock at an exercise price of $7.142857 per share. On August 24, 2017, the Series T holders exercised the warrants and acquired the 700 million shares of the Corporation’s common stock using the Series T preferred stock as consideration for the exercise price, which increased common shares outstanding, but had no effect on diluted earnings per share as this conversion had been included in the Corporation’s diluted earnings per share calculation under the applicable accounting guidance. The use of the Series T preferred stock as consideration represents a non-cash financing activity and, accordingly, is not reflected in the Consolidated Statement of Cash Flows. For 2016 and 2015, the 700 million average dilutive potential common shares were included in the diluted share count under the “if-converted” method.
For 2017, 2016 and 2015, 62 million average dilutive potential common shares associated with the Series L preferred stock were not included in the diluted share count because the result would have been antidilutive under the “if-converted” method. For 2017, 2016 and 2015, average options to purchase 21 million, 45 million and 66 million shares of common stock, respectively, were outstanding but not included in the computation of EPS because the result would have been antidilutive under the treasury stock method. For 2017, 2016 and 2015, average warrants to purchase 122 million shares of common stock were outstanding but not included in the computation of EPS because the result would have been antidilutive under the treasury stock method. For 2017, average warrants to purchase 143 million shares of common stock were included in the diluted EPS calculation under the treasury stock method compared to 150 million shares of common stock in both 2016 and 2015.